Is AstraZeneca's adenovirus technology behind the blood clots?
3 minutes to read
16th April 2021
This week, US health authorities recommended pausing the rollout of the one-shot Johnson & Johnson/Janssen COVID-19 vaccine while investigations into exceptionally rare blood clots take place.
Six women suffered blood clots out of nearly seven million doses administered.
The J&J vaccine uses broadly similar vaccine technology as the AstraZeneca vaccine, known as
